Virginia National Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,458
Closed -$343K 41
2022
Q2
$343K Sell
4,458
-539
-11% -$41.1K 0.54% 48
2022
Q1
$365K Buy
+4,997
New +$336K 0.42% 52

Other funds holding BMY

Virginia National Bank's BMY Position: Q3 2022 in Review

Virginia National Bank sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 4,458 shares — an estimated $343K sold.

Virginia National Bank first reported a position in BMY in Q1 2022 and held it in 2 quarters. The position peaked at $365K in Q1 2022. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Virginia National Bank reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
  • Virginia National Bank sold 4,458 Bristol-Myers Squibb shares in Q3 2022, an estimated $343K.
  • Virginia National Bank first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 2 quarters.
  • Virginia National Bank's Bristol-Myers Squibb position peaked at $365K in Q1 2022.
  • 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Virginia National Bank's 13F filing for Q3 2022, filed 4 Nov 2022.